1. Shah CPHeier JS. YAG Laser Vitreolysis vs Sham YAG Vitreolysis for Symptomatic Vitreous Floaters: A Randomized Clinical TrialJAMA Ophthalmol. 2017 Sep 1;135(9):918-923. doi: 10.1001/jamaophthalmol.2017.2388.
  2. Kokavec JWu ZSherwin JCAng AJAng GS. Nd:YAG laser vitreolysis versus pars plana vitrectomy for vitreous floaters. Cochrane Database Syst Rev. 2017 Jun 1;6:CD011676. doi: 10.1002/14651858.CD011676.pub2
  3. Delaney YMOyinloye ABenjamin L. Nd:YAG vitreolysis and pars plana vitrectomy: surgical treatment for vitreous floaters. Eye (Lond). 2002 Jan;16(1):21-6.
  4. Vandorselaer TVan De Velde FTassignon MJ. Eligibility criteria for Nd-YAG laser treatment of highly symptomatic vitreous floaters. Bull Soc Belge Ophtalmol. 2001;(280):15-9.
  5. Vogel AHentschel WHolzfuss JLauterborn W. Cavitation bubble dynamics and acoustic transient generation in ocular surgery with pulsed neodymium: YAG lasersOphthalmology. 1986 Oct;93(10):1259-69.
  6. Lim JI. YAG Laser Vitreolysis-Is It as Clear as It Seems? JAMA Ophthalmol. 2017Sep1;135(9):924-925. 
  7. Milston R Madigan MCSebag J. Vitreous floaters: Etiology, diagnostics, and management. Surv Ophthalmol. 2016 Mar-Apr;61(2):211-27. doi: 10.1016/j.survophthal.2015.11.008. Epub 2015 Dec 8
  8. Kasimov ÉMAlieva NIMamedzade AN. Results of YAG-laser vitreolysis in proliferative diabetic retinopathy complicated by vitreous hemorrhage (Article in Russian).  Vestn Oftalmol. 2014 Jul-Aug;130(4):22-6.
  9. Gao YB. Vitreolysis with Nd:YAG laser (Article in Chinese). Zhonghua Yan Ke Za Zhi. 1990 Nov;26(6):352-4.
  10. Fankhauser FKwasniewska S. Laser Vitreolysis. A review. Ophthalmologica. 2002 Mar-Apr;216(2):73-84
  11. Levy JHPisacano AM. Clinical experience with Nd:YAG laser vitreolysis in the anterior segment. J Cataract Refract Surg. 1987 Sep;13(5):548-50.
  12. Hosseini HMehryar MFarvardin M. Triamcinolone-assisted neodymium:YAG laser vitreolysis. Ophthalmic Surg Lasers Imaging. 2008 May-Jun;39(3):234-6.
  13. Little HLJack RL. Q-switched neodymium: YAG laser surgery of the vitreous. Graefes Arch Clin Exp Ophthalmol. 1986;224(3):240-6.
  14. Fankhauser FKwasniewska Svan der Zypen E. Vitreolysis with the Q-switched laser. Arch Ophthalmol. 1985 Aug;103(8):1166-71
  15. Tchah HRosenberg MLarson RSLindstrom RL. Neodymium: YAG laser vitreolysis for treatment and prophylaxis of cystoid macular oedema. Aust N Z J Ophthalmol. 1989 May;17(2):179-83.
  16. Tassignon MJNí Dhubhghaill SRuiz Hidalgo IRozema JJ. Subjective Grading of Subclinical Vitreous Floaters. Asia Pac J Ophthalmol (Phila). 2016 Mar-Apr;5(2):104-9. 
  17. Mamou JWa CAYee KMSilverman RHKetterling JASadun AASebag J. Ultrasound-based quantification of vitreous floaters correlates with contrast sensitivity and quality of life. Invest Ophthalmol Vis Sci. 2015 Jan 22;56(3):1611-7. doi: 10.1167/iovs.14-15414.
  18. Garcia GA , Khoshnevis MYee KMPNguyen-Cuu JNguyen JHSebag J. Degradation of Contrast Sensitivity Function Following Posterior Vitreous Detachment. Am J Ophthalmol. 2016 Dec;172:7-12. doi: 10.1016/j.ajo.2016.09.005. Epub 2016 Sep 12.
  19. Garcia GAKhoshnevis MYee KMPNguyen JHNguyen-Cuu JSadun AASebag JThe effects of aging vitreous on contrast sensitivity function. Graefes Arch Clin Exp Ophthalmol. 2018 May;256(5):919-925. doi: 10.1007/s00417-018-3957-1. Epub 2018 Mar 13.
  20. Webb BFWebb JRSchroeder MCNorth CS. Prevalence of vitreous floaters in a community sample of smartphone users. Int J Ophthalmol. 2013 Jun 18;6(3):402-5. doi: 10.3980/j.issn.2222-3959.2013.03.27. Print 2013.
  21. Singh IP. Novel OCT Application and Optimized YAG Laser Enable Visualization and Treatment of Mid- to Posterior Vitreous Floaters. Ophthalmic Surg Lasers Imaging Retina. 2018 Oct 01;49(10):806-811
  22. Brasse K, Schmitz-Valckenberg S, Jünemann A, Roider J, Hoerauf H. YAG laser vitreolysis for treatment of symptomatic vitreous opacities . Ophthalmologe. 2019 Jan;116(1):73-84.
  23. Bergstrom RCzyz CN. Vitreous Floaters. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jun 10ƒƒ
  24. Cohen MNRahimy EHo ACGarg SJ. Management of Symptomatic Floaters: Current Attitudes, Beliefs, and Practices Among Vitreoretinal Surgeons. Ophthalmic Surg Lasers Imaging Retina. 2015 Sep;46(8):859-65. doi: 10.3928/23258160-20150909-11.
  25. Nguyen JHNguyen-Cuu JYu FYee KMMamou JSilverman RHKetterling JSebag J. Assessment of Vitreous Structure and Visual Function after Neodymium:Yttrium-Aluminum-Garnet Laser Vitreolysis. Ophthalmology. 2019 Jun 22. pii: S0161-6420(18)32553-3. doi: 10.1016/j.ophtha.2019.06.021.
  26. Sebag JSadun AA. Re: Thompson: Much Ado about Nothing (or Something)-What Is the Role of Vitrectomy and Yttrium-Aluminum-Garnet Laser for Vitreous Floaters? Ophthalmol Retina. 2019 Jul;3(7):e6. doi: 10.1016/j.oret.2019.01.025. Epub 2019 Apr 3.
  27. Sebag JYee KMWa CAHuang LCSadun AA.Vitrectomy for floaters: prospective efficacy analyses and retrospective safety profile. Retina. 2014 Jun;34(6):1062-8. doi: 10.1097/IAE.0000000000000065.
  28. Sebag J Vitreous: Not just through it. Clin Exp Ophthalmol. 2016 Sep;44(7):547-549. doi: 10.1111/ceo.12823.
  29. Rostami BNguyen-Cuu JBrown GBrown MSadun AASebag J. Cost-Effectiveness of Limited Vitrectomy for Vision-Degrading Myodesopsia. Am J Ophthalmol. 2019 Aug;204:1-6. doi: 10.1016/j.ajo.2019.02.032. Epub 2019 Mar 6.
  30. Wa CSebag J. Safety of vitrectomy for floaters. Am J Ophthalmol. 2011 Dec;152(6):1077; author reply 1077-8. doi: 10.1016/j.ajo.2011.09.003.
  31. Sebag J. Floaters and the quality of life. Am J Ophthalmol. 2011 Jul;152(1):3-4.e1. doi: 10.1016/j.ajo.2011.02.015.
  32. Sebag J. To see the invisible: the quest of imaging vitreous. Dev Ophthalmol. 2008;42:5-28. doi: 10.1159/000138754.
  33. Sauvage FFraire JCRemaut KSebag JPeynshaert KHarrington MVan de Velde FJXiong RTassignon MJBrans TBraeckmans KDe Smedt SC  Photoablation of Human Vitreous Opacities by Light-Induced Vapor Nanobubbles. ACS Nano. 2019 Jul 23;13(7):8401-8416. doi: 10.1021/acsnano.9b04050. Epub 2019 Jul 12
  34. Vandorselaer T1Van De Velde FTassignon MJ. Eligibility criteria for Nd-YAG laser treatment of highly symptomatic vitreous floaters. Bull Soc Belge Ophtalmol. 2001;(280):15-9.
  35. Van der Veken AVan de velde FSmeets BTassignon MJ. Nd:YAG laser posterior hyaloidotomy for the treatment of a premacular vitreous floater. Bull Soc Belge Ophtalmol. 1997;265:39-43.
  36. Tassignon MJKreissig IStempels NBrihaye M. Indications for Q-switched and mode-locked Nd: YAG lasers in vitreoretinal pathology. Eur J Ophthalmol. 1991 Jul-Sep;1(3):123-30.
  37. van Overdam KAvan Etten PGvan Meurs JCManning SS. Vitreous Wiping, a new technique for removal of vitreous cortex remnants during vitrectomy. Acta Ophthalmol. 2019 Aug;97(5):e747-e752. doi: 10.1111/aos.13991. Epub 2018 Dec 7.
  38. Wu RHZhang RLin ZLiang QHMoonasar N. A comparison between topical and retrobulbar anesthesia in 27-gauge vitrectomy for vitreousfloaters: a randomized controlled trial. BMC Ophthalmol. 2018 Jul 7;18(1):164. doi: 10.1186/s12886-018-0838-7.
  39. Lin ZMoonasar NWu RHSeemongal-Dass RR. 27-Gauge Vitrectomy for Symptomatic Vitreous Floaters with Topical Anesthesia. Case Rep Ophthalmol. 2017 Jan 20;8(1):35-39. doi: 10.1159/000453332. eCollection 2017 Jan-Apr.
  40. Sun XTian JWang JZhang JWang YYuan G Nd:YAG Laser Vitreolysis for Symptomatic Vitreous Floaters: Application of Infrared Fundus Photography in Assessing the Treatment Efficacy. J Ophthalmol. 2019 Jan 27;2019:8956952. doi: 10.1155/2019/8956952. eCollection 2019.
  41. Schiff WM1Chang SMandava NBarile GR. Pars plana vitrectomy for persistent, visually significant vitreous opacities. Retina. 2000;20(6):591-6.
  42. ChiTing Horng, FuAn Chen, DaihHuang Kuo, LiChai Chen, ShouShan Yeh, and PoChuen Shieh. Pharmacologic vitreolysis of vitreous floaters by 3-month pineapple supplement in Taiwan: A pilot study. J Am Sci 2019;15(4):1730
  43. Luo JAn XKuang Y. Efficacy and safety of yttrium-aluminium garnet (YAG) laser vitreolysis for vitreous floaters. J Int Med Res. 2018 Nov;46(11):4465-4471. doi: 10.1177/0300060518794245. Epub 2018 Sep 10.
  44. 44.Sommerville DN. Vitrectomy for vitreous floaters: analysis of the benefits and risks. Curr Opin Ophthalmol. 2015 May;26(3):173-6.
  45. Patel SBSnyder MERiemann CDOsher JMMi CWSisk RA. Combined phacoemulsification surgery with multifocal intraocular lens implantation and pars plana vitrectomy for symptomatic vitreous opacities. Retin Cases Brief Rep. 2019 Apr 8, doi: 10.1097/ICB.0000000000000873.
  46. Shaimova VAShaimov TBShaimov RBGalin AYGoloshchapova ZARyzhkov PKFomin AV Evaluation of YAG-laser vitreolysis effectiveness based on quantitative characterization of vitreous floaters (article in Russian) Vestn Oftalmol. 2018;134(1):56-62. doi: 10.17116/oftalma2018134156-62.
  47. Sun ITLee THChen CH Rapid Cataract Progression after Nd:YAG Vitreolysis for Vitreous Floaters: A Case Report and Literature Review. Case Rep Ophthalmol. 2017 May 29;8(2):321-325. doi: 10.1159/000477159. eCollection 2017 May-Aug.
  48. Danzig CHariprasad SM. Surgical management of symptomatic vitreous floaters. Ophthalmic Surg Lasers Imaging Retina. 2014 Nov-Dec;45(6):1-3. doi: 10.3928/23258160-20141118-01.
  49. Hurst JJohnson DLaw CSchweitzer KSharma S. Value of subjective visual reduction in patients with acute-onset floaters and/or flashes. Can J Ophthalmol. 2015 Aug;50(4):265-8. doi: 10.1016/j.jcjo.2015.06.001.